	Robotic bladder diverticulectomy in patients with bladder diverticulum neoplasia: a single-center study. Arch Ital Urol Androl Falabella R, Porreca A, Foschi N, Salvaggio A, Digianfrancesco L, Barone B, Crocetto F, Caputo VF. PMID: 41496692 [PubMed - indexed for MEDLINE]
	A national perspective on the management of high-risk BCG-unresponsive non-muscle-invasive bladder cancer in Romania. Arch Ital Urol Androl Buzoianu M, Buhas BA, Abou Chakra M, Ionutas E, Borz MB, Crisan N, O'Donnell MA. PMID: 41496691 [PubMed - indexed for MEDLINE]
	Clinical and functional outcome of salvage vesiculectomy for local prostate cancer recurrence: a single-arm meta-analysis. Arch Ital Urol Androl Thamran B, Kadar DD. PMID: 41496681 [PubMed - indexed for MEDLINE]
	Adult urologic sarcomas: a single institution experience over 25 years. Can J Urol Arham AB, Rieth JM, O'Donnell MA. PMID: 41496538 [PubMed - indexed for MEDLINE]
	Performance of fluorescence in situ hybridization in detecting lower versus upper tract urothelial carcinoma. Can J Urol Xu S, Lu M, Yang Z, Zheng H. PMID: 41496535 [PubMed - indexed for MEDLINE]
	Modern diagnostics: ultrasound elastography and magnetic resonance imaging in initial evaluation of testicular cancer. Can J Urol Arik , Güvenç . PMID: 41496534 [PubMed - indexed for MEDLINE]
	Adverse histological features are more commonly observed in hypergonadotropic prostate cancer patients. Can J Urol Shatylko T, Safiullin R, Gamidov S, Ivanets T, Mammaev R, Guluzade K, Rodin I, Sukhikh G. PMID: 41496533 [PubMed - indexed for MEDLINE]
	Sexual health distress and needs after radical prostatectomy: a scoping review. Sex Med Rev Li Y, Yu D, Wang D, Wu X, Cheng H, Liu J, Yi H. PMID: 41496183 [PubMed - indexed for MEDLINE]
	YY1 in prostate cancer: multidimensional oncogenicmechanisms and emerging therapeutic vulnerabilities. J Mol Histol Liu Q, Liang Z, Li L, Wen R, Mo L, Liu Y, Wang X. PMID: 41495564 [PubMed - in process]
	Congenital nephrotic syndrome in a newborn with glycogen storage disease and Wilms tumor 1 (WT1) mutation. CEN Case Rep Annicchiarico Petruzzelli L, De Marco O, Improda N, Giannattasio P, Luongo I, Carucci M, Brunetti B, Serio V, Minale B, Malgieri G. PMID: 41495530 [PubMed - indexed for MEDLINE]
	Retraction Note: The effect of Ganoderma lucidum polysaccharide extract on sensitizing prostate cancer cells to flutamide and docetaxel: an in vitro study. Sci Rep Rahimnia R, Akbari MR, Yasseri AF, Taheri D, Mirzaei A, Ghajar HA, Farashah PD, Baghdadabad LZ, Aghamir SMK. PMID: 41495158 [PubMed - in process]
	Unraveling the microbial landscape in prostate cancer: pathogenesis to therapy. NPJ Biofilms Microbiomes Du X, Wu J, Xia S, Zheng H, Zhang B. PMID: 41495053 [PubMed - as supplied by publisher]
	Breaking barriers in prostate cancer: the mRNA vaccine breakthrough and what comes next. NPJ Vaccines Rajabi R, Vafaei S, Afrashteh F, Ghods R, Madjd Z. PMID: 41495048 [PubMed - as supplied by publisher]
	Radiographic Progression-Free Survival as a Surrogate Endpoint for Overall Survival in First-Line ARPi NaÃ¯ve Metastatic Castration-Resistant Prostate Cancer. Oncologist Castro E, Paganelli S, Wang D, Haltner A, Niyazov A, Chang J, Samjoo IA, Barata PC. PMID: 41495009 [PubMed - as supplied by publisher]
	Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: Long-term Data from the SAKK 09/10 Randomised Phase 3 Trial. Eur Urol Ghadjar P, Hayoz S, Zwahlen DR, Hölscher T, Arnold W, Polat B, Hildebrandt G, Hoffmann E, Plasswilm L, Papachristofilou A, Schär C, Sumila M, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti DG, Khanfir K, Riesterer O, Beck M, Thalmann GN, Aebersold DM, Swiss Group for Clinical Cancer Research (SAKK). PMID: 41494929 [PubMed - as supplied by publisher]
	Randomized trial of dose de-escalation in low-risk prostate cancer patients implanted with Pd-103. Brachytherapy King M, Miri, Sayan M, Galbreath R, Fiano R, Wallner K, Orio P. PMID: 41494910 [PubMed - as supplied by publisher]
	Amino Acid Metabolic Reprogramming in Clear Cell Renal Cell Carcinoma: Pathogenic Mechanisms and Therapeutic Targeting. Cancer Lett Xie J, Ni F, Shao J, Zhang D, Guo T, Wang X. PMID: 41494569 [PubMed - as supplied by publisher]
	Development and validation of a deep vein thrombosis risk nomogram for post-operative complications in prostate cancer patients. Clin Invest Med Zheng D. PMID: 41493767 [PubMed - indexed for MEDLINE]
	Persistent lymph node uptake on [18Â F]-FDG PET-CT after neoadjuvant chemotherapy: a major predictive factor of disease-free survival in MIBC. World J Urol Pattou M, Robert G, Gouhizoun O, Guéna F, Khaddad A, Mebroukine S, Margue G, Gross-Goupil M, Lefort F, Morgat C, Bernhard JC, Bladou F, Klein C. PMID: 41493567 [PubMed - indexed for MEDLINE]
	A phase 1, first-in-human, dose escalation study of JNJ-80038114, a PSMAxCD3 bispecific antibody, in participants with metastatic castration-resistant prostate cancer. Cancer Chemother Pharmacol Hudson A, Jayaram A, Garmezy B, Zorko NA, Zarrabi KK, Mathews L, Rupnow B, Li M, Ghosh D, Urtishak K, Francis P, Wang SC, Attiyeh E, de Bono J. PMID: 41493473 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 175037

Page 1 of 8752



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy